• In September, Herbalife Ltd. authorized a US$250 million share repurchase program and, earlier this month, presented at the Maxim Growth Summit 2026 in New York, where Senior VP of Finance & Transformation Scott Schaefer discussed the company's initiatives.

• This combination of capital return plans and public communication about Herbalife's transformation efforts adds fresh context to how investors may view its longer-term positioning.

• We'll now examine how Herbalife's new US$250 million buyback program could influence the existing investment narrative around cash flow and risk.

Outshine the giants: these 19 early-stage AI stocks could fund your retirement .

Herbalife Investment Narrative Recap

To own Herbalife today, you have to believe its shift toward personalized nutrition, digital tools and emerging markets can offset pressure from weaker regions like China and EMEA and recent margin compression, while its leveraged balance sheet remains manageable. The new US$250 million buyback and Maxim Growth Summit appearance highlight cash return ambitions and a more visible transformation story, but they do not fundamentally change the near term focus on cash generation and execution risk in slower markets.

The buyback authorization is the clearest recent development linked to this story, sitting alongside years of refinancing activity and debt reduction efforts. Together, these moves frame Herbalife as a company trying to balance de‑leveraging with returning capital, which matters for how investors think about free cash flow, interest coverage and equity risk. Whether that balance holds will likely depend more on earnings quality than on the buyback headline itself.

But alongside the upside from buybacks and new products, investors should also be aware of the added India GST costs and what they could mean for margins...

Read the full narrative on Herbalife (it's free!)

Herbalife's narrative projects $5.6 billion revenue and $465.5 million earnings by 2029. This requires 2.6% yearly revenue growth and a $301.3 million earnings increase from $164.2 million today.

Uncover how Herbalife's forecasts yield a $17.00 fair value , a 20% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were assuming earnings could almost triple to about US$469.1 million by 2029, yet the new buyback and tax headwinds in India show how quickly the balance between growth and margin risk might shift, so it is worth comparing these bullish assumptions with your own view before deciding which narrative feels closer to reality.